Dispatch
Insights for revenue cycle leaders
RCM trends, denial analysis, and operational strategy from the Exactrx team.
Seven RCM platforms compared for ASCs and outpatient practices: first-pass rates, deployment timelines, pricing, and specialty fit.
H-1B visa fees create unexpected budget drains for healthcare organizations already facing workforce shortages and margin pressure.
The 2.48% rate bump masks fundamental changes to risk scoring that could upend how MA plans negotiate with providers.
Ten risk-reduction strategies finance leaders can use to evaluate healthcare innovation investments and protect margins.
Which integration method fits your billing workflow? A practical guide to HL7, APIs, FHIR, and direct EMR connections.
Pharmaceutical lawsuits challenging 340B patient definitions could eliminate millions in ASC drug savings overnight.
Smart CFOs are turning mandatory price disclosure into competitive intelligence for revenue optimization and market positioning.
The 2.48% Medicare Advantage rate bump translates to 4.98% more plan revenue, reshaping your negotiating position for 2027 contracts.
CMS is expanding prior authorization in 2026. See how new rules impact surgical and procedural practices and how to protect revenue.
Most Tennessee ASCs aren’t ready for CMS’s new prior auth demo. Here’s what’s in scope, how it works, and the workflows you need now.